Dr. Vince Willard, Director of Regenerative Therapies, Co-Authors Two Papers on Genetic Engineering

Dr. Vince Willard recently co-authored two papers studying applications of gene editing of stem cells to prevent inflammation. One paper, entitled “CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues,” published in the May 2017 edition of Arthritis & Rheumatology. The other paper, “Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop […]

Continue reading


Cytex President Dr. Farsh Guilak Presides Over 2017 Meeting of the Orthopaedic Research Society

Cytex is proud to have Dr. Farsh Guilak preside over the 2017 meeting of the Orthopaedic Research Society in San Diego on March 19th through 22nd, 2017. In addition to serving as president of Cytex Therapeutics, Dr. Farsh Guilak is Professor of Orthopaedic Research and the Co-Director of Regenerative Medicine at Washington University, and one of […]

Continue reading


Cytex Technology Featured on Breakthroughs in Bioscience

Cytex’s 3-D weave technology is featured as this fall’s cover image on the Regenerative Medicine issue of Breakthroughs in Bioscience, a journal highlighting scientific breakthroughs important to society.  The publication is produced by Federation of American Societies for Experimental Biology (FASEB), the nation’s largest coalition of biomedical researchers.

Continue reading


Cytex Accepted in NIH Commercialization Acceleration Program

Cytex is delighted to be awarded entry to the highly successful Commercialization Acceleration Program offered as a competitive award to recipients of NIH Phase II SBIR or STTR awards.  The program provides training and support for Cytex staff in commercialization activities such as regulatory planning, investment negotiations, and product marketing.

Continue reading